Abstract
Adaptive enrichment designs (AEDs) of clinical trials allow investigators to restrict enrollment to a promising subgroup based on an interim analysis. Most of the existing AEDs deal with a small number of predefined subgroups, which are often unknown at the design stage. The newly developed Simon design offers a great deal of flexibility in subgroup selection (without requiring pre-defined subgroups) but does not provide a procedure for estimating and testing treatment efficacy for the selected subgroup. This article proposes a 2-stage AED which does not require predefined subgroups but requires a prespecified algorithm for choosing a subgroup on the basis of baseline covariate information. Having a prespecified algorithm for subgroup selection makes it possible to use cross-validation and bootstrap methods to correct for the resubstitution bias in estimating treatment efficacy for the selected subgroup. The methods are evaluated and compared in a simulation study mimicking actual clinical trials of human immunodeficiency virus infection.
Original language | English (US) |
---|---|
Pages (from-to) | 1-11 |
Number of pages | 11 |
Journal | Statistics in Medicine |
Volume | 37 |
Issue number | 1 |
DOIs | |
State | Published - Jan 15 2018 |
Keywords
- bootstrap
- cross-validation
- precision medicine
- predictive biomarker
- subgroup analysis
- treatment effect heterogeneity
ASJC Scopus subject areas
- Epidemiology
- Statistics and Probability